The authors attempted to cross GFAP-KI mice with mice harboring deletion of the tumor suppressor Trp53 to enhance glioma formation, but these mice displayed a broad spectrum of systemic tumors due to the leaky expression of CRE. Here, GFAP is linked to central nervous system cancer.